Editorial
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Sep 26, 2024; 12(27): 6020-6026
Published online Sep 26, 2024. doi: 10.12998/wjcc.v12.i27.6020
Clinical approach for pulmonary lymphatic disorders
Chalisa Thamkittikun, Prakarn Tovichien
Chalisa Thamkittikun, Prakarn Tovichien, Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand
Co-first authors: Chalisa Thamkittikun and Prakarn Tovichien
Author contributions: Thamkittikun C and Tovichien P designed the overall concept, outlined the manuscript, reviewed the literature, and wrote and edited the manuscript; and all authors have read and approved the final manuscript.
Conflict-of-interest statement: Chalisa Thamkittikun and Prakarn Tovichien have nothing to disclose.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: Https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Prakarn Tovichien, MD, Associate Professor, Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Wanglang Road, Bangkok Noi, Bangkok 10700, Thailand. prakarn.tov@mahidol.edu
Received: April 22, 2024
Revised: June 20, 2024
Accepted: June 25, 2024
Published online: September 26, 2024
Processing time: 98 Days and 5.9 Hours
Core Tip

Core Tip: The pulmonary lymphatic perfusion syndrome likely stems from an inherent variation in the lymphatic system, leading to various pulmonary lymphatic disorders. Clinically, it manifests as conditions such as plastic bronchitis, chylothorax, and interstitial lung disease. Recent advancements in dynamic contrast-enhanced magnetic resonance lymphangiography have improved our understanding of these pathophysiologies and contributed to the development of interventional therapies.